Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference
January 04, 2022 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the H.C....
22157.jpg
Worldwide Hematology Testing Industry to 2027 - by Product, Test Type, End-user and Geography
December 22, 2021 05:18 ET | Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Hematology Testing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and...
PRPO logo.png
New York State Approves Precipio’s HemeScreen for POL clinical use
November 18, 2021 10:00 ET | Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021
October 25, 2021 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that analyses from the global Phase 3 roxadustat clinical program will be presented at the American...
PRPO logo.png
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
August 26, 2021 10:00 ET | Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
22157.jpg
Global Chemotherapy-Induced Anemia Clinical Landscape Market Report 2021: Amgen Leads Industry Sponsors with the Highest Overall Number of Clinical Trials for CIA, Followed by Johnson & Johnson
June 21, 2021 04:43 ET | Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Chemotherapy-Induced Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...
22157.jpg
Global Sickle Cell Anemia Market Report 2021-2031: Key Marketed and Pipeline Drugs, Clinical Trials, Recent Events, Regulatory Events, Success Probability, Disease Prevalence, Licensing & Acquisition
June 09, 2021 08:53 ET | Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Sickle Cell...
PRPO logo.png
Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
June 08, 2021 10:30 ET | Precipio, Inc.
 Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
TIP_link_300x300.jpg
Hematology Analyzers and Reagents Market Growth Sturdy at 7.6% CAGR to Outstrip $13,007.87 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 07, 2021 10:46 ET | The Insight Partners
Pune, India., June 07, 2021 (GLOBE NEWSWIRE) -- Hematology Analyzers and Reagents Market: Key InsightsAccording to our new research study on “Hematology Analyzers and Reagents Market to 2027 –...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Present at Upcoming Investor Conferences
May 27, 2021 07:00 ET | FibroGen, Inc
SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following...